![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Altman DG. 1991. Practical statistics for medical research. London: Chapman and Hall.
- Leyngar LR, Rao VA, Kumar S. 1982. Significance of amniotic fluid glucose in pregnancy. Internal Journal of Gynaecology Obstetrics 20:57–63.
- Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N. 2003. Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Research and Clinical Practice 62:47–53.
- Ozgu-Erdinc AS, Cavkaytar S, Aktulay A, Buyukkagnici U, Erkaya S, Danisman N. 2014. Mid-trimester maternal serum and amniotic fluid biomarkers for the prediction of preterm delivery and intrauterine growth retardation. Journal of Obstetrics and Gynaecology Research 40:1540–1546.
- Rinala SG, Drythout VL, Lambers DS. 2009. Correlation of glucose concentrations in maternal serum and amniotic fluid in high-risk pregnancies.. American Journal of Obstetrics Gynecology 200:e43–e44.
- Romem Y, Loven A, Agam G, Leiberman JR. 1993. The temporal relationship between maternal blood and amniotic fluid glucose levels. American Journal of Obstetrics and Gynecology 168:611–614.
- Star J, Canick JA, Palomaki GE, Carpenter MW, Saller DN, Jr, Sung CJ, et al. 1997. The relationship between second-trimester amniotic fluid insulin and glucose levels and subsequent gestational diabetes. Prenatal Diagnosis 17:149–154.
- Serlin DC, Lash RW. 2009. Diagnosis and management of gestational diabetes mellitus. American Family Physician 80:57–62.
- Stefos T, Sotiriadis A, Kaponis A, Dalkalitsis N, Lolis D. 2003. Amniotic fluid glucose at the time of genetic amniocentesis: correlation with duration of pregnancy and birthweight. European Journal Of Obstetrics Gynecology Reproductive Biology 106:144–147.
- Tisi DK, Burns DH, Luskey GW, Koski KG. 2011. Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus. Diabetes Care 34:139–144.
- Teh WT, Teede HJ, Paul E, Harrison CL, Wallace EM, Allan C. 2011. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Australian New Zealand Journal of Obstetrics and Gynaecology 51:26–30.
- Weiss PA, Hofmann H, Winter R, Purstner P, Lichtenegger W. 1985. Amniotic fluid glucose values in normal and abnormal pregnancies. Obstetrics and Gynecology 65:333–339.
- Yoneda S, Sakai M, Sasaki Y, Shiozaki A, Hidaka T, Saito S. 2007. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes. Journal. of Obstetrics and Gynaecology Research 33:38–44.